Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
25.88
-2.03 (-7.27%)
Oct 16, 2025, 3:37 PM EDT - Market open

Oruka Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024
Period Ending
Oct '25 Dec '24
1,252679
Enterprise Value
1,001325
Last Close Price
27.9119.39
PB Ratio
3.071.78
P/TBV Ratio
3.961.79
Debt / Equity Ratio
0.010.00
Quick Ratio
27.1228.80
Current Ratio
27.4228.89
Earnings Yield
-5.73%-13.46%
FCF Yield
-7.12%-9.33%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q